At EY, we’re all in to shape your future with confidence. We’ll help you succeed in a globally connected powerhouse of diverse teams and take your career wherever you want it to go. Join EY and
At EY, we’re all in to shape your future with confidence. We’ll help you succeed in a globally connected powerhouse of diverse teams and take your career wherever you want it to go. Join EY and
Req ID: 133254 Remote Position: No Region: Asia Country: Japan State/Province: Miyagi City: Miyagi General Overview Functional Area: OPS - Operations Career Stream: CPM - Customer Program Management Role: Specialist SAP Short Name: SPE Job Title:
Req ID: 133251 Remote Position: No Region: Asia Country: Japan State/Province: Miyagi City: Miyagi General Overview Functional Area: Supply Chain Management (SCM) Career Stream: Purchasing (SCM_PUR) Role: Analyst Job Title: Buyer Job Code: ANA-SCM-BUY Band: Level
Req ID: 133253 Remote Position: No Region: Asia Country: Japan State/Province: Miyagi City: Miyagi General Overview Functional Area: Supply Chain Management (SCM) Career Stream: Planning & Inventory (SCM_PNIV) Role: Analyst Job Title: Planner Job Code: ANA-SCM-PLAN
At EY, you’ll have the chance to build a career as unique as you are, with the global scale, support, inclusive culture and technology to become the best version of you. And we’re counting on your
At EY, you’ll have the chance to build a career as unique as you are, with the global scale, support, inclusive culture and technology to become the best version of you. And we’re counting on your
Job Description: Department Overview The EC Expansion Development Department is guided by a mindset of building a lean and efficient organization, and delivers products and systems that continuously strengthen and expand e-commerce. In a fast-changing business
At EY, you’ll have the chance to build a career as unique as you are, with the global scale, support, inclusive culture and technology to become the best version of you. And we’re counting on your
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)